These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26573231)

  • 1. Auranofin is a potent suppressor of osteosarcoma metastasis.
    Topkas E; Cai N; Cumming A; Hazar-Rethinam M; Gannon OM; Burgess M; Saunders NA; Endo-Munoz L
    Oncotarget; 2016 Jan; 7(1):831-44. PubMed ID: 26573231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Thioredoxin Reductase Inhibitor Auranofin Suppresses Pulmonary Metastasis of Osteosarcoma, But Not Local Progression.
    Kinoshita H; Shimozato O; Ishii T; Kamoda H; Hagiwara Y; Tsukanishi T; Ohtori S; Yonemoto T
    Anticancer Res; 2021 Oct; 41(10):4947-4955. PubMed ID: 34593442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rheumatoid arthritis drug auranofin exerts potent anti-lymphoma effect by stimulating TXNRD-mediated ROS generation and inhibition of energy metabolism.
    Yang M; Liu J; Li J; Wen S; Hu Y; Lu W; Liu J; Huang P; Liu P
    Redox Biol; 2024 Sep; 75():103245. PubMed ID: 38909408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
    Wang H; Bouzakoura S; de Mey S; Jiang H; Law K; Dufait I; Corbet C; Verovski V; Gevaert T; Feron O; Van den Berge D; Storme G; De Ridder M
    Oncotarget; 2017 May; 8(22):35728-35742. PubMed ID: 28415723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer.
    Oh BM; Lee SJ; Cho HJ; Park YS; Kim JT; Yoon SR; Lee SC; Lim JS; Kim BY; Choe YK; Lee HG
    Cell Death Dis; 2017 Mar; 8(3):e2682. PubMed ID: 28300829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
    Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
    Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of endogenous antioxidants with Auranofin causes mitochondrial oxidative stress which can be countered by selenium supplementation.
    Radenkovic F; Holland O; Vanderlelie JJ; Perkins AV
    Biochem Pharmacol; 2017 Dec; 146():42-52. PubMed ID: 28947276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents.
    Buddingh EP; Kuijjer ML; Duim RA; Bürger H; Agelopoulos K; Myklebost O; Serra M; Mertens F; Hogendoorn PC; Lankester AC; Cleton-Jansen AM
    Clin Cancer Res; 2011 Apr; 17(8):2110-9. PubMed ID: 21372215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications.
    Parashar S; Cheishvili D; Arakelian A; Hussain Z; Tanvir I; Khan HA; Szyf M; Rabbani SA
    Cancer Med; 2015 May; 4(5):732-44. PubMed ID: 25619880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
    Raninga PV; Lee AC; Sinha D; Shih YY; Mittal D; Makhale A; Bain AL; Nanayakarra D; Tonissen KF; Kalimutho M; Khanna KK
    Int J Cancer; 2020 Jan; 146(1):123-136. PubMed ID: 31090219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of thioredoxin reductase by auranofin induces apoptosis in adriamycin-resistant human K562 chronic myeloid leukemia cells.
    Liu JJ; Liu Q; Wei HL; Yi J; Zhao HS; Gao LP
    Pharmazie; 2011 Jun; 66(6):440-4. PubMed ID: 21699084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the metastatic phenotype of a panel of established osteosarcoma cells.
    Ren L; Mendoza A; Zhu J; Briggs JW; Halsey C; Hong ES; Burkett SS; Morrow J; Lizardo MM; Osborne T; Li SQ; Luu HH; Meltzer P; Khanna C
    Oncotarget; 2015 Oct; 6(30):29469-81. PubMed ID: 26320182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupting YAP1-mediated glutamine metabolism induces synthetic lethality alongside ODC1 inhibition in osteosarcoma.
    Wang H; Tao Y; Han J; Shen J; Mu H; Wang Z; Wang J; Jin X; Zhang Q; Yang Y; Lin J; Sun M; Ma X; Ren L; LeBlanc AK; Xu J; Hua Y; Sun W
    Cell Oncol (Dordr); 2024 Oct; 47(5):1845-1861. PubMed ID: 39115605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth.
    Johnson SS; Liu D; Ewald JT; Robles-Planells C; Pulliam C; Christensen KA; Bayanbold K; Wels BR; Solst SR; O'Dorisio MS; Menda Y; Spitz DR; Fath MA
    Cancer Biol Ther; 2024 Dec; 25(1):2382524. PubMed ID: 39054566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auranofin induces apoptosis by ROS-mediated ER stress and mitochondrial dysfunction and displayed synergistic lethality with piperlongumine in gastric cancer.
    Zou P; Chen M; Ji J; Chen W; Chen X; Ying S; Zhang J; Zhang Z; Liu Z; Yang S; Liang G
    Oncotarget; 2015 Nov; 6(34):36505-21. PubMed ID: 26431378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
    Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
    Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
    Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
    Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis.
    Endo-Munoz L; Cai N; Cumming A; Macklin R; Merida de Long L; Topkas E; Mukhopadhyay P; Hill M; Saunders NA
    PLoS One; 2015; 10(8):e0133592. PubMed ID: 26317203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
    Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
    Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Auranofin and Celecoxib Suppresses the Local Progression and Pulmonary Metastases of Osteosarcoma
    Kinoshita H; Kinoshita S; Kamoda H; Hagiwara Y; Ohtori S; Yonemoto T
    Anticancer Res; 2024 Mar; 44(3):1045-1049. PubMed ID: 38423669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.